Nutra Pharma Announces Delivery of Nyloxina to New Vitality

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that New , a marketing and distribution company, has placed and received their first order of the Company's all-natural, non-addictive pain reliever, Nyloxin.

http://it.tmcnet.com/news/2013/08/29/7374718.htm

Nutra Pharma Announces Delivery of Nyloxina to New Vitality

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that New Vitality, a marketing and distribution company, has placed and received their first order of the Company's all-natural, non-addictive pain reliever, ... (more)

http://www.businesswire.com/news/topix/20130829005257/en